SLE cells bound significantly less Gal-1 than control cells, indicating that terminal N-acetyllactosamine side chains, the Gal-1 ligands, were less accessible on these cells (Figure 1B). This evidence concerns the gene LGALS1 and systemic lupus erythematosus.